bucladesine has been researched along with Dysembryoma in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 53 (64.63) | 18.7374 |
1990's | 28 (34.15) | 18.2507 |
2000's | 1 (1.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campisi, J; Gudas, LJ; Levine, RA; Wang, SY | 1 |
Gudas, LJ; LaRosa, GJ; Levine, RA | 1 |
Adamson, E; Hogan, BL; Taylor, A | 1 |
Anderson, WB; Jetten, AM; Nagarajan, L | 1 |
Crowley, C; Rizzino, A | 1 |
Fewell, JW; Kuff, EL | 1 |
Marotti, KR; Smith, KK; Strickland, S | 1 |
Crnek, V; Skreb, N | 1 |
Anderson, WB; Binet, E; Evain, D | 1 |
Muramatsu, H; Muramatsu, T | 2 |
Levine, AJ; Oren, M; Reich, NC | 1 |
Dessau, W; Prehm, P; Timpl, R | 1 |
Lehman, JM; Trevor, K | 1 |
Horak, I; Schmidt, M; Wecker, E | 1 |
Bender, B; Carlin, BE; Chung, AE; Durkin, ME; Jaffe, R | 1 |
Gudas, LJ; Wang, SY | 3 |
Barlow, DP; Helfman, DM; Hogan, BL; Kurkinen, M; Williams, JG | 1 |
Kudo, T; Narimatsu, H | 1 |
Alitalo, K; Bracke, M; Mummery, CL; van den Eijnden-van Raaij, J; van Rooyen, M; van Zoelen, EJ | 1 |
Cummings, RD; Zhou, Q | 1 |
Chao, CC; Lin-Chao, S; Sun, NK | 1 |
Kim, KW; Lee, HY; Lee, YH; Ryu, SH; Suh, PG | 1 |
Imada, M; Imada, S; Katayanagi, S; Shirayoshi, Y; Uyeno, M | 1 |
Bae, SK; Chung, HY; Jeong, CH; Kim, KW; Koo, SY; Lee, YM; Raleigh, JA; Son, MJ; Song, HS; Yoo, MA | 1 |
Levinson, BB; Linney, E | 1 |
Mahdavi, V; Strickland, S | 1 |
Gudas, LJ; Rosenberg, RD; Soff, G; Weiler-Guettler, H; Yu, K | 1 |
Hirayoshi, K; Kudo, H; Nagata, K; Nakai, A; Saga, S; Takechi, H | 1 |
Boncinelli, E; Detmer, K; Largman, C; Lawrence, HJ; Prochazka, V; Safaei, R | 1 |
Kobarai, Y; Kosaka, M; Nishikawa, S; Nishimune, Y; Nishina, Y; Sumi, T | 1 |
Becker, S; Casanova, J; Grabel, L | 1 |
Heiermann, R; Lang, E; Maelicke, A; Rentrop, M | 1 |
Kohda, T; Kondo, K; Oishi, M | 1 |
Helaakoski, T; Kivirikko, KI; Pajunen, L; Pihlajaniemi, T | 1 |
Imada, M; Imada, S; Yamaguchi, H | 1 |
Trevor, KT | 1 |
Carpani, G; Garattini, E; Gianni, M; Studer, M; Terao, M | 1 |
Darrow, AL; Rickles, RJ; Strickland, S | 2 |
Huang, RP; Kadomatsu, K; Muramatsu, T; Ozawa, M | 1 |
Nakagawa, M; Nakanishi, N; Yamada, S | 1 |
Kisliakova, TV; Pospelov, VA; Pospelova, TV | 1 |
Gudas, LJ; Hu, L | 1 |
Burbelo, PD; Horikoshi, S; Yamada, Y | 1 |
Martin, CA; Napoli, JL; Ziegler, LM | 2 |
Galvin-Parton, PA; Malbon, CC; Watkins, DC | 1 |
Amos, B; Lotan, R | 1 |
Chan, SD; King, KL; Nissenson, RA; Strewler, GJ | 1 |
Ishikawa, H; Ishiwata, C; Ishiwata, I; Nozawa, S; Soma, M; Tomita, K | 1 |
Adamson, ED; Grover, A | 2 |
Benson, SC; Bush, GL | 1 |
Casanova, JE; Grabel, LB | 1 |
Adamson, ED; Edwards, SA; Rundell, AY | 1 |
Pecorino, LT; Rickles, RJ; Strickland, S | 1 |
Kurki, P; Laasonen, A; Lehtonen, E; Tan, EM | 1 |
Gudas, LJ; Stoner, CM | 1 |
Braunhut, SJ; D'Amore, PA; Gudas, LJ; Kurokawa, T; Sasse, J | 1 |
Gudas, LJ; Roguska, MA; Wang, SY | 1 |
Adler, RR; Ziomek, CA | 1 |
Lang, E; Maelicke, A; Mazauric-Stüker, ML | 1 |
Chambon, P; Gold, JD; Gudas, LJ; Petkovich, M; Vasios, GW | 1 |
Lehtonen, E; Soinila, S; Tienari, J; Virtanen, I | 1 |
Kitagawa, Y; Miki, K; Sugimoto, E | 1 |
Fukuda, M; Ikuma, S; Setoyama, C; Shimada, K | 1 |
Alonso, A; Bouterfa, H; Breuer, B; Doenecke, D | 1 |
Lalitha, VS; Mungale, SD; Thakare, AV | 1 |
Pacenti, L; Rusciano, D; Terrana, B | 1 |
Colberg-Poley, AM; Dony, C; Gruss, P; Püschel, AW; Voss, SD | 1 |
Church, RL; Davidson, JN; Rao, GN | 1 |
Balicki, D; Mukherjee, BB; Newrock, KM; Rodrigues, M | 1 |
Gudas, LJ; LaRosa, GJ; Wang, SY | 1 |
Rechardt, L; Wartiovaara, J | 1 |
Dziadek, M; Timpl, R | 1 |
Gudas, LJ; Roguska, MA | 1 |
Kitagawa, Y; Morita, A; Sugimoto, E | 1 |
Joukoff, E; Keil-Dlouha, V; Planchenault, T | 1 |
Grippo, JF; Gudas, LJ | 1 |
82 other study(ies) available for bucladesine and Dysembryoma
Article | Year |
---|---|
Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
Topics: Acetates; Animals; Bucladesine; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Flow Cytometry; Mice; Plasminogen Activators; Teratoma; Theophylline; Tretinoin | 1984 |
Isolation of cDNA clones for genes exhibiting reduced expression after differentiation of murine teratocarcinoma stem cells.
Topics: Animals; Bucladesine; Cell Differentiation; DNA; Electrophoresis, Polyacrylamide Gel; Embryonal Carcinoma Stem Cells; Gene Expression Regulation; Hot Temperature; Mice; Neoplastic Stem Cells; Protein Biosynthesis; RNA, Neoplasm; Stem Cells; Teratoma; Transcription, Genetic | 1984 |
Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm.
Topics: alpha-Fetoproteins; Animals; Bucladesine; Cell Aggregation; Cell Differentiation; Cell Line; Clone Cells; Embryo, Mammalian; Mice; Teratoma; Tretinoin | 1981 |
A new differentiated cell line (Dif 5) derived by retinoic acid treatment of F9 teratocarcinoma cells capable of extracellular matrix production and growth in the absence of serum.
Topics: alpha-Fetoproteins; Animals; Blood; Bucladesine; Cell Division; Cell Line; Cell Separation; Culture Media; Endoderm; Epidermal Growth Factor; Extracellular Matrix; Myristic Acids; Neoplasms, Experimental; Plasminogen Activators; Teratoma; Tretinoin | 1983 |
Growth and differentiation of embryonal carcinoma cell line F9 in defined media.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Division; Cell Line; Culture Media; Fibronectins; Insulin; Mice; Neoplasms, Experimental; Plasminogen Activators; Teratoma; Transferrin; Tretinoin | 1980 |
Induction of neural-like cells and acetylcholinesterase activity in cultures of F9 teratocarcinoma treated with retinoic acid and dibutyryl cyclic adenosine monophosphate.
Topics: Acetylcholinesterase; Animals; Bucladesine; Cell Differentiation; Culture Techniques; Endoderm; Enzyme Induction; Mice; Neoplasms, Experimental; Nervous System; Teratoma; Tretinoin | 1980 |
Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Collagen; Endoderm; Mice; Plasminogen Activators; Proteins; Teratoma; Tretinoin | 1980 |
Development of embryo-derived teratomas in vitro.
Topics: Animals; Bucladesine; Cell Communication; Cell Differentiation; Cell Transformation, Neoplastic; Cells, Cultured; Culture Media; DNA; Embryo, Mammalian; Germ Layers; Mice; Rats; Species Specificity; Teratoma | 1980 |
Alterations in calcitonin and parathyroid hormone responsiveness of adenylate cyclase in F9 embryonal carcinoma cells treated with retinoic acid and dibutyryl cyclic AMP.
Topics: Adenylyl Cyclases; Animals; Bucladesine; Calcitonin; Cell Differentiation; Cell Division; Cell Line; Female; Isoproterenol; Mice; Parathyroid Hormone; Pregnancy; Teratoma; Tretinoin | 1981 |
Decreased synthesis of large fucosyl glycopeptides during differentiation of embryonal carcinoma cells induced by retinoic acid and dibutyryl cyclic AMP.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Fucose; Galactose; Glycopeptides; Mice; Teratoma; Tretinoin | 1982 |
Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Transformation, Viral; Cells, Cultured; Fibroblasts; Mice; Mice, Inbred BALB C; Phosphoproteins; RNA, Messenger; Simian virus 40; Teratoma; Tretinoin; Tumor Suppressor Protein p53 | 1982 |
Rates of synthesis of basement membrane proteins by differentiating teratocarcinoma stem cells and their modulation by hormones.
Topics: Animals; Ascorbic Acid; Basement Membrane; Bucladesine; Cell Line; Collagen; Electrophoresis, Polyacrylamide Gel; Fluorescent Antibody Technique; Glycoproteins; Growth Substances; Kinetics; Laminin; Mice; Teratoma; Tretinoin | 1982 |
The interaction of polyoma virus with F9 embryonal carcinoma cells and chemically induced differentiated progeny: fate of the viral DNA and expression of viral antigens.
Topics: Animals; Antigens, Viral; Bucladesine; Cell Differentiation; Cell Line; DNA, Viral; Polyomavirus; Teratoma; Transfection; Tretinoin; Tumor Virus Infections | 1982 |
In vitro differentiation of F-9 teratocarcinoma cells does not induce expression of endogenous retroviral glycoprotein.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Mice; Neoplasms, Experimental; Retroviridae; Teratoma; Tretinoin; Viral Envelope Proteins; Viral Proteins | 1982 |
Synthesis of laminin and entactin by F9 cells induced with retinoic acid and dibutyryl cyclic AMP.
Topics: Animals; Basement Membrane; Bucladesine; Cell Line; Fluorescent Antibody Technique; Glycoproteins; Kinetics; Laminin; Membrane Glycoproteins; Membrane Proteins; Mice; Neoplasms, Experimental; Teratoma; Tretinoin | 1983 |
Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells.
Topics: Animals; Bucladesine; Cell Line; Cloning, Molecular; Collagen; DNA; Genes; Glycoproteins; Laminin; Mice; Neoplasms, Experimental; Nucleic Acid Hybridization; Protein Biosynthesis; RNA, Neoplasm; Teratoma; Theophylline; Tretinoin | 1983 |
Isolation of cDNA clones for basal lamina components: type IV procollagen.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Cloning, Molecular; Collagen; DNA; Embryo, Mammalian; Endoderm; Female; Mice; Nucleic Acid Hybridization; Pregnancy; Procollagen; Protein Biosynthesis; Rabbits; Reticulocytes; RNA, Messenger; Teratoma; Tretinoin | 1983 |
A fucosyltransferase in teratocarcinoma stem cells. Decreased activity accompanying differentiation to parietal endoderm cells.
Topics: Bucladesine; Cell Differentiation; Cell Line; Embryonal Carcinoma Stem Cells; Fucosyltransferases; Hexosyltransferases; Neoplastic Stem Cells; Stem Cells; Surface Properties; Teratoma; Tretinoin | 1983 |
Selection and characterization of F9 teratocarcinoma stem cell mutants with altered responses to retinoic acid.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Division; Cell Line; Kinetics; Mice; Mutation; Neoplasm Proteins; Teratoma; Theophylline; Tretinoin | 1984 |
The beta 1,4-galactosyltransferase gene is post-transcriptionally regulated during differentiation of mouse F9 teratocarcinoma cells.
Topics: Animals; Base Sequence; Bucladesine; Cell Differentiation; Drug Stability; Gene Expression Regulation, Neoplastic; Kinetics; Mice; Molecular Sequence Data; N-Acetyllactosamine Synthase; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1995 |
Fibroblast growth factor-mediated growth regulation and receptor expression in embryonal carcinoma and embryonic stem cells and human germ cell tumours.
Topics: Animals; Blotting, Northern; Bucladesine; Cell Differentiation; Cell Division; Cell Line; Culture Media, Conditioned; Down-Regulation; Embryo, Mammalian; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Fibroblast Growth Factor 4; Fibroblast Growth Factors; Laminin; Liver; Mice; Poly A; Proto-Oncogene Proteins; Rats; Rats, Inbred BUF; Receptors, Fibroblast Growth Factor; RNA; RNA, Messenger; Stem Cells; Teratoma; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1993 |
L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion.
Topics: Animals; Bucladesine; Carbohydrate Sequence; Cell Adhesion; Cell Differentiation; CHO Cells; Chromatography, Affinity; Cricetinae; Cysteine; Disaccharides; Enzyme-Linked Immunosorbent Assay; Galactose; Galactosides; Galectins; Glycopeptides; Glycoproteins; Hemagglutinins; Laminin; Methionine; Mice; Molecular Sequence Data; Polysaccharides; Sulfur Radioisotopes; Teratoma; Tretinoin; Tritium; Tumor Cells, Cultured | 1993 |
Characterization of a DNA-damage-recognition protein from F9 teratocarcinoma cells, which is inducible by retinoic acid and cyclic AMP.
Topics: Animals; Avian Sarcoma Viruses; Bucladesine; Cell Differentiation; Cell Nucleus; Cyclic AMP; DNA; DNA Damage; HeLa Cells; Humans; Mice; Nuclear Proteins; Promoter Regions, Genetic; Teratoma; Transfection; Tretinoin; Tumor Cells, Cultured; Ultraviolet Rays | 1993 |
Reduced expression of PLC-gamma during the differentiation of mouse F9 teratocarcinoma cells.
Topics: Animals; Blotting, Northern; Blotting, Western; Bucladesine; Cell Differentiation; Gene Expression Regulation, Neoplastic; Mice; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoric Diester Hydrolases; Teratoma; Theophylline; Tretinoin; Tumor Cells, Cultured | 1993 |
Cyclic AMP-mediated augmentation of thrombomodulin gene expression: cell type-dependent usage of control regions.
Topics: 3T3 Cells; Animals; Base Sequence; Bucladesine; Cloning, Molecular; Cycloheximide; DNA Mutational Analysis; Enhancer Elements, Genetic; Gene Expression; Genes; Mice; Molecular Sequence Data; Promoter Regions, Genetic; Receptors, Cell Surface; Receptors, Thrombin; Restriction Mapping; RNA, Messenger; Teratoma; Thymidine Kinase | 1993 |
Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development.
Topics: Animals; Antibodies, Monoclonal; Biomarkers; Blood Vessels; Brain; Bucladesine; Cell Differentiation; Cell Hypoxia; DNA-Binding Proteins; Embryonic and Fetal Development; Endothelial Growth Factors; Endothelium, Vascular; Gene Expression Regulation, Developmental; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lymphokines; Mice; Mice, Inbred BALB C; Nitroimidazoles; Nuclear Proteins; Platelet Endothelial Cell Adhesion Molecule-1; Stem Cells; Teratoma; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Teratocarcinoma differentiation: plasminogen activator activity associated with embryoid body formation.
Topics: Alkaline Phosphatase; Bucladesine; Cell Differentiation; Cell Line; Endoderm; Enzyme Induction; Plasminogen Activators; Teratoma; Theophylline; Toxins, Biological; Vibrio cholerae | 1977 |
The induction of differentiation in teratocarcinoma stem cells by retinoic acid.
Topics: Acetylglucosaminidase; Alkaline Phosphatase; Bucladesine; Cell Differentiation; Cell Line; Collagen; Endoderm; Enzyme Induction; Neoplasms, Experimental; Plasminogen Activators; Teratoma; Tretinoin; Vitamin A | 1978 |
Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells.
Topics: Animals; Base Sequence; Bucladesine; Cell Line; Cell Nucleus; Cyclic AMP; Gene Expression Regulation, Neoplastic; Mice; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Receptors, Cell Surface; Receptors, Thrombin; RNA, Neoplasm; Teratoma; Theophylline; Thrombin; Transcription, Genetic; Tretinoin | 1992 |
Molecular cloning of a mouse 47-kDa heat-shock protein (HSP47), a collagen-binding stress protein, and its expression during the differentiation of F9 teratocarcinoma cells.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Bucladesine; Cell Differentiation; Cloning, Molecular; Collagen; DNA; Electrophoresis, Gel, Two-Dimensional; Heat-Shock Proteins; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Precipitin Tests; RNA, Messenger; Teratoma; Tretinoin; Tumor Cells, Cultured | 1992 |
Modulation of HOX2 gene expression following differentiation of neuronal cell lines.
Topics: Animals; Blotting, Northern; Bucladesine; Cell Differentiation; Gene Expression; Genes, Homeobox; Glioma; Humans; Mice; Nerve Growth Factors; Neuroblastoma; Neurons; RNA, Neoplasm; Teratoma; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1992 |
Expression of c-kit protooncogene is stimulated by cAMP in differentiated F9 mouse teratocarcinoma cells.
Topics: Animals; Blotting, Northern; Bucladesine; Cell Differentiation; Gene Expression Regulation, Neoplastic; Laminin; Mice; Precipitin Tests; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Proto-Oncogenes; Receptors, Cell Surface; Teratoma; Tissue Plasminogen Activator; Tretinoin; Tumor Cells, Cultured | 1992 |
Localization of endoderm-specific mRNAs in differentiating F9 embryoid bodies.
Topics: alpha-Fetoproteins; Animals; Blotting, Northern; Bucladesine; Cell Differentiation; Endoderm; Enzyme Induction; Enzyme-Linked Immunosorbent Assay; Mice; Neoplasm Proteins; Nucleic Acid Hybridization; Organoids; RNA, Messenger; RNA, Neoplasm; Teratoma; Tissue Plasminogen Activator; Tretinoin | 1992 |
Expression of retinoic acid nuclear receptors in the mouse embryonal carcinoma cell line PCC7-Mz1.
Topics: Animals; Blotting, Northern; Bucladesine; Carrier Proteins; Cell Differentiation; Cell Nucleus; Mice; Poly A; Receptors, Retinoic Acid; RNA; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1992 |
Cellular HSP90 (HSP86) mRNA level and in vitro differentiation of mouse embryonal carcinoma (F9) cells.
Topics: Animals; Blotting, Northern; Bucladesine; Cell Differentiation; Endoderm; Gene Expression; Heat-Shock Proteins; In Vitro Techniques; Mice; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1991 |
Increases in mRNA concentrations of the alpha and beta subunits of prolyl 4-hydroxylase accompany increased gene expression of type IV collagen during differentiation of mouse F9 cells.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Blotting, Northern; Bucladesine; Cell Differentiation; Cell Line; Collagen; DNA Probes; Gene Expression Regulation; Genes; Glyceraldehyde-3-Phosphate Dehydrogenases; Kinetics; Macromolecular Substances; Mice; Procollagen-Proline Dioxygenase; RNA, Messenger; Teratoma; Tretinoin; Tumor Cells, Cultured | 1990 |
Differential expression of fetomodulin and tissue plasminogen activator to characterize parietal endoderm differentiation of F9 embryonal carcinoma cells.
Topics: Animals; Antibodies, Monoclonal; Bucladesine; Cell Differentiation; Cell Line; Endoderm; Gene Expression; Kinetics; Membrane Glycoproteins; Methionine; Mice; Nucleic Acid Hybridization; RNA; RNA, Messenger; Teratoma; Tissue Plasminogen Activator; Tretinoin | 1990 |
Disruption of keratin filaments in embryonic epithelial cell types.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Cytoskeleton; Desmosomes; Endoderm; Intermediate Filaments; Keratins; Mice; Morphogenesis; Recombinant Fusion Proteins; Teratoma; Tretinoin; Tumor Cells, Cultured; Vimentin | 1990 |
Retinoic acid induces liver/bone/kidney-type alkaline phosphatase gene expression in F9 teratocarcinoma cells.
Topics: Alkaline Phosphatase; Animals; Blotting, Northern; Blotting, Western; Bone and Bones; Bucladesine; Cycloheximide; Dactinomycin; Enzyme Induction; Gene Expression Regulation, Enzymologic; Kidney; Liver; Mice; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1991 |
Maintenance and use of F9 teratocarcinoma cells.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Culture Media; Culture Techniques; Mice; Teratoma; Transfection; Tretinoin | 1990 |
Developmentally regulated expression of embigin, a member of the immunoglobulin superfamily found in embryonal carcinoma cells.
Topics: Amino Acid Sequence; Animals; Base Sequence; Bucladesine; DNA; Embryonic and Fetal Development; Endoderm; Female; Fibroblasts; Gene Expression; Glycoproteins; Immunoglobulins; Mice; Molecular Sequence Data; Neoplasm Transplantation; Ovary; Pregnancy; RNA, Messenger; Teratoma; Tretinoin; Tumor Cells, Cultured; Uterus | 1990 |
[Effect of retinoic acid, dibutyryl cyclic AMP, and nerve growth factor on NADPH-specific dihydropteridine reductase of teratoma 402AX cells in culture].
Topics: Biopterins; Bucladesine; Dihydropteridine Reductase; Humans; Nerve Growth Factors; Teratoma; Tretinoin; Tumor Cells, Cultured | 1990 |
[The growth and morphological characteristics of undifferentiated and differentiated cells of the F9 mouse teratocarcinoma line].
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; Biomarkers, Tumor; Bucladesine; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Glycolipids; Lewis X Antigen; Mice; Phenotype; Teratoma; Tretinoin; Tumor Cells, Cultured | 1990 |
Cyclic AMP analogs and retinoic acid influence the expression of retinoic acid receptor alpha, beta, and gamma mRNAs in F9 teratocarcinoma cells.
Topics: Animals; Blotting, Northern; Bucladesine; Carrier Proteins; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation; Mice; Receptors, Retinoic Acid; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1990 |
DNA methylation and collagen IV gene expression in F9 teratocarcinoma cells.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Clone Cells; Collagen; DNA, Neoplasm; Gene Expression; Methylation; Mice; RNA, Messenger; Teratoma; Transfection; Tretinoin; Tumor Cells, Cultured | 1990 |
Retinoic acid, dibutyryl-cAMP, and differentiation affect the expression of retinoic acid receptors in F9 cells.
Topics: Animals; Bucladesine; Carrier Proteins; Cell Differentiation; Cell Line; Cell Nucleus; DNA Probes; Gene Expression; Kinetics; Nucleic Acid Hybridization; Receptors, Retinoic Acid; Restriction Mapping; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin | 1990 |
Enhanced expression of c-fos is not obligatory for retinoic acid-induced F9 cell differentiation.
Topics: Blood; Bucladesine; Cell Differentiation; Gene Expression; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1990 |
Retinoic acid modulation of transmembrane signaling. Analysis in F9 teratocarcinoma cells.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Endoderm; GTP-Binding Proteins; Isoproterenol; Kinetics; Mice; Receptors, Adrenergic, beta; Signal Transduction; Teratoma; Tissue Plasminogen Activator; Tretinoin | 1990 |
Modulation of lysosomal-associated membrane glycoproteins during retinoic acid-induced embryonal carcinoma cell differentiation.
Topics: Animals; Antigens, CD; Bucladesine; Cell Differentiation; Cell Line; Fluorescent Antibody Technique; Glycoside Hydrolases; Glycosylation; Immunoblotting; Kinetics; Laminin; Lectins; Lysosomal Membrane Proteins; Lysosomes; Membrane Glycoproteins; Mice; Molecular Weight; Protein Processing, Post-Translational; Teratoma; Tretinoin | 1990 |
Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.
Topics: Adenylyl Cyclases; Animals; Bucladesine; Cell Differentiation; Endoderm; Mice; Neoplasm Proteins; Parathyroid Hormone-Related Protein; Peptide Fragments; Protein Biosynthesis; Proteins; Receptors, Cell Surface; Receptors, Parathyroid Hormone; RNA, Messenger; RNA, Neoplasm; Teratoma; Tretinoin; Tumor Cells, Cultured | 1990 |
Establishment and characterization of HUOT, a human ovarian malignant teratoma cell line producing alpha-fetoprotein.
Topics: Adult; alpha-Fetoproteins; Animals; Bucladesine; Cell Division; Cell Line; Chromosome Aberrations; Female; Humans; Mice; Mice, Inbred BALB C; Ovarian Neoplasms; Teratoma; Transplantation, Heterologous | 1985 |
Evidence for the existence of an early common biochemical pathway in the differentiation of F9 cells into visceral or parietal endoderm: modulation by cyclic AMP.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bucladesine; Cell Aggregation; Cell Differentiation; Cell Line; Collagen; Cyclic AMP; Electrophoresis, Polyacrylamide Gel; Endoderm; Enzyme-Linked Immunosorbent Assay; Fibronectins; Fluorescent Antibody Technique; Laminin; Mice; Teratoma | 1986 |
Conditions affecting the differentiation of F9 teratocarcinoma cells: potentiation of response by cyclic AMP.
Topics: alpha-Fetoproteins; Animals; Bucladesine; Cell Differentiation; Cell Line; Culture Media; Embryonal Carcinoma Stem Cells; Endoderm; Laminin; Mice; Neoplastic Stem Cells; Teratoma; Tretinoin | 1986 |
The effect of cyclic AMP on the accumulation of newly synthesized protein in the extracellular matrix of PFHR-9 teratocarcinoma cells.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Bucladesine; Cell Division; Cell Line; Colforsin; Collagen; Cyclic AMP; DNA; Extracellular Matrix; Proline; Protein Biosynthesis; Teratoma | 1987 |
The role of cell interactions in the differentiation of teratocarcinoma-derived parietal and visceral endoderm.
Topics: alpha-Fetoproteins; Animals; Bucladesine; Cell Communication; Cell Differentiation; Ectoderm; Endoderm; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Immunosorbent Techniques; Keratins; Mice; Microscopy, Electron; RNA, Messenger; Stem Cells; Teratoma; Tissue Plasminogen Activator; Tretinoin; Tumor Cells, Cultured; Viscera | 1988 |
Expression of c-fos antisense RNA inhibits the differentiation of F9 cells to parietal endoderm.
Topics: Bucladesine; Cell Differentiation; Collagen; DNA, Recombinant; Endoderm; Fluorescent Antibody Technique; Gene Expression Regulation; Immunoenzyme Techniques; Laminin; Nucleic Acid Hybridization; Plasmids; Proteoglycans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; RNA; RNA, Antisense; RNA, Messenger; Simian virus 40; Teratoma; Transcription, Genetic; Transfection; Tretinoin; Tumor Cells, Cultured | 1988 |
Anti-sense inhibition of tissue plasminogen activator production in differentiated F9 teratocarcinoma cells.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Collagen; Mice; Phenotype; Plasmids; RNA; RNA, Complementary; RNA, Messenger; Teratoma; Tissue Plasminogen Activator | 1988 |
Cell proliferation and expression of cytokeratin filaments in F9 embryonal carcinoma cells.
Topics: Actin Cytoskeleton; Animals; Antigens, Neoplasm; Bucladesine; Cell Differentiation; Cell Division; Keratins; Mice; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Teratoma; Tretinoin; Tumor Cells, Cultured | 1989 |
Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells.
Topics: Base Sequence; Bucladesine; Carrier Proteins; Cell Differentiation; Cloning, Molecular; DNA; Humans; Molecular Sequence Data; Receptors, Retinoic Acid; RNA, Messenger; Teratoma; Theophylline; Tretinoin | 1989 |
Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation.
Topics: Animals; Blotting, Northern; Blotting, Western; Bucladesine; Cell Differentiation; DNA Probes; Embryonal Carcinoma Stem Cells; Fibroblast Growth Factors; Heparin; Mice; Neoplastic Stem Cells; Teratoma; Tretinoin; Tumor Cells, Cultured | 1989 |
Defective post-translational modification of collagen IV in a mutant F9 teratocarcinoma cell line is associated with delayed differentiation and growth arrest in response to retinoic acid.
Topics: Animals; Ascorbic Acid; Bucladesine; Cell Differentiation; Cell Division; Cell Line; Collagen; Hydroxylation; Kinetics; Laminin; Mutation; Procollagen-Proline Dioxygenase; Protein Processing, Post-Translational; RNA, Messenger; Teratoma; Theophylline; Transcription, Genetic; Tretinoin | 1989 |
Induction of murine 8-cell blastomere polarity by F9 embryonal carcinoma cells.
Topics: Animals; Blastomeres; Bucladesine; Cell Adhesion; Cell Communication; Cell Differentiation; Embryonal Carcinoma Stem Cells; Embryonic and Fetal Development; Embryonic Induction; Female; Fibroblasts; Lymphocytes; Mice; Neoplastic Stem Cells; Stimulation, Chemical; Teratoma; Tretinoin; Tumor Cells, Cultured | 1989 |
States of developmental commitment of a mouse embryonal carcinoma cell line differentiating along a neural pathway.
Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Bucladesine; Cell Differentiation; Cell Line; Clone Cells; Complement System Proteins; Mice; Nerve Tissue Proteins; Neurons; Teratoma; Tretinoin | 1989 |
A retinoic acid-responsive element is present in the 5' flanking region of the laminin B1 gene.
Topics: Animals; Base Sequence; Bucladesine; Cell Differentiation; Cell Line; Chloramphenicol O-Acetyltransferase; Gene Expression Regulation; Genes; Genetic Vectors; HeLa Cells; Humans; Laminin; Macromolecular Substances; Mice; Molecular Sequence Data; Promoter Regions, Genetic; Restriction Mapping; Teratoma; Thymidine Kinase; Transcription, Genetic; Transfection; Tretinoin | 1989 |
Neuron-like derivatives of cultured F9 embryonal carcinoma cells express characteristics of parietal endoderm cells.
Topics: Animals; Antibodies, Monoclonal; Bucladesine; Cell Differentiation; Cell Line; Endoderm; Mice; Neoplasm Proteins; Nerve Growth Factors; Neurons; Teratoma; Tretinoin | 1987 |
Reversible interconversion between primitive endoderm- and parietal endoderm-like F9 cells demonstrated by mRNAs expression.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Cloning, Molecular; DNA; Embryo, Mammalian; Endoderm; Laminin; Mice; Protein Biosynthesis; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin | 1987 |
Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation.
Topics: Animals; Bucladesine; Cell Differentiation; Cloning, Molecular; DNA; Gene Expression Regulation; Mice; Molecular Sequence Data; RNA, Messenger; Teratoma; Tissue Plasminogen Activator; Tretinoin; Tumor Cells, Cultured | 1988 |
Decrease in the c-myb gene transcript during differentiation of mouse teratocarcinoma stem cells.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; DNA, Neoplasm; Embryonal Carcinoma Stem Cells; Mice; Neoplastic Stem Cells; Proto-Oncogenes; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin | 1987 |
Protein synthesis inhibitors prevent the induction of laminin B1, collagen IV (alpha 1), and other differentiation-specific mRNAs by retinoic acid in F9 teratocarcinoma cells.
Topics: Animals; Aphidicolin; Bucladesine; Cell Line; Collagen; Dichlororibofuranosylbenzimidazole; Diterpenes; Gene Expression Regulation; Laminin; Protein Synthesis Inhibitors; Puromycin; Retinol-Binding Proteins; RNA, Messenger; Teratoma; Tretinoin | 1988 |
Early increase in histone H1(0) mRNA during differentiation of F9 cells to parietal endoderm.
Topics: Amino Acid Sequence; Animals; Base Sequence; Bucladesine; Cell Cycle; Cell Differentiation; Cloning, Molecular; Endoderm; Gene Expression Regulation; Histones; Mice; Molecular Sequence Data; RNA, Messenger; Teratoma; Tretinoin | 1988 |
Inducer mediated in vitro differentiation in a neurogenic transplantable murine teratocarcinoma.
Topics: 5'-Nucleotidase; Animals; Bucladesine; Cell Differentiation; Dimethyl Sulfoxide; Mice; Neoplasm Transplantation; Nucleotidases; Teratoma; Tretinoin | 1988 |
Organ colonization pattern of retinoic acid-treated and -untreated mouse embryonal carcinoma F9 cells.
Topics: Animals; Bucladesine; Cell Line; Fucose; Glycolipids; Glycosylation; Lewis X Antigen; Liver Neoplasms; Lung Neoplasms; Mice; Neoplasm Metastasis; Teratoma; Tretinoin | 1987 |
Post-transcriptional regulation of a murine homeobox gene transcript in F9 embryonal carcinoma cells.
Topics: Animals; Bucladesine; Carcinoma; Embryonal Carcinoma Stem Cells; Gene Expression Regulation; Genes, Homeobox; Mice; Neoplastic Stem Cells; RNA Processing, Post-Transcriptional; Teratoma; Tretinoin | 1987 |
Posttranscriptional regulation of the expression of CAD gene during differentiation of F9 teratocarcinoma cells by induction with retinoic acid and dibutyryl cyclic AMP.
Topics: Actins; Amidohydrolases; Animals; Aspartate Carbamoyltransferase; Bucladesine; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Differentiation; Cell Division; Dihydroorotase; DNA; Gene Expression Regulation; Ligases; Mice; Nucleic Acid Hybridization; RNA, Messenger; Teratoma; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1988 |
Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells.
Topics: Actins; Animals; Bucladesine; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Cell Transformation, Neoplastic; Deoxyglucose; Embryonal Carcinoma Stem Cells; Epidermal Growth Factor; ErbB Receptors; Fibronectins; Mice; Neoplasm Proteins; Neoplastic Stem Cells; Phosphoproteins; Plasminogen Activators; Receptors, Cell Surface; Teratoma; Tretinoin; Tumor Suppressor Protein p53 | 1985 |
Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Nucleus; Cells, Cultured; Cloning, Molecular; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes; Mice; Nucleic Acid Hybridization; Protein Biosynthesis; Teratoma; Theophylline; Transcription, Genetic; Tretinoin | 1985 |
Neural differentiation in embryonal carcinoma cells.
Topics: Acetylcholinesterase; Animals; Bucladesine; Cell Differentiation; Cell Line; Culture Techniques; Endoderm; Mice; Neurons; Phenotype; Teratoma; Tretinoin | 1985 |
Expression of nidogen and laminin in basement membranes during mouse embryogenesis and in teratocarcinoma cells.
Topics: Animals; Basement Membrane; Bucladesine; Electrophoresis, Polyacrylamide Gel; Embryonic Development; Female; Fluorescent Antibody Technique; Immunosorbent Techniques; Laminin; Membrane Glycoproteins; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred Strains; Pregnancy; Radioimmunoassay; Teratoma; Tretinoin | 1985 |
An increase in prolyl-4-hydroxylase activity occurs during the retinoic acid-induced differentiation of mouse teratocarcinoma stem cell lines F9 and P19.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Collagen; Endoderm; Fibroblasts; Immunosorbent Techniques; Kinetics; Mice; Procollagen-Proline Dioxygenase; Protein Processing, Post-Translational; Stem Cells; Teratoma; Theophylline; Tretinoin | 1985 |
Reversible effects of dibutyryl cAMP on laminin and type IV collagen secretion from retinoic acid treated F9 cells.
Topics: Animals; Bucladesine; Cell Count; Cell Line; Collagen; Endoderm; Laminin; Methionine; Mice; Protein Biosynthesis; RNA, Messenger; Teratoma; Tretinoin | 1985 |
Changes of surface glycoproteins after retinoic acid-dibutyryl cAMP-induced differentiation of teratocarcinoma stem cells.
Topics: Animals; Bucladesine; Cell Differentiation; Cell Line; Concanavalin A; Electrophoresis, Polyacrylamide Gel; Embryonal Carcinoma Stem Cells; Glycoproteins; Immunologic Techniques; Laminin; Lectins; Neoplastic Stem Cells; Receptors, Mitogen; Surface Properties; Teratoma; Tretinoin; Wheat Germ Agglutinins | 1986 |
The effect of dibutyryl cyclic AMP and butyrate on F9 teratocarcinoma cellular retinoic acid-binding protein activity.
Topics: Animals; Bucladesine; Butyrates; Butyric Acid; Carrier Proteins; Cell Differentiation; Cell Line; Cyclic AMP; Cytosol; Kinetics; Mice; Receptors, Retinoic Acid; Teratoma | 1987 |